Collagen News and Research

Latest Collagen News and Research

Rxi's new RNAi preclinical data to be presented at Keystone conference

RXi Pharmaceuticals Corporation, a recognized leader in RNA interference based therapeutic discovery and development, today announced that new preclinical data using proprietary self-delivering RNAi compounds, including RXI-109, will be presented at the Keystone Symposia's Mechanism and Biology of Silencing conference being held March 20-25, 2011 in Monterey, California.

22 Mar 2011

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

FibroGen, Inc., today announced that FibroGen and partner Astellas Pharma Inc. advanced FG-4592 (Astellas designation ASP1517), an investigational anemia therapy, to phase 2b development for treatment of anemia in chronic kidney disease (CKD) patients on dialysis and not on dialysis.

18 Mar 2011

Electric devices can improve aging skin

It may seem as if new developments to combat aging skin are being introduced faster than the speed of light. At the forefront of the research, dermatologists are underpinning these advancements, refining the basic understanding of how the skin ages in order to develop more effective non-invasive cosmetic procedures and products.

16 Mar 2011

Non-laser light treatments may help treat common skin conditions

While dermatologists have used lasers successfully for years to treat common skin conditions such as acne, rosacea and aging skin, it now appears that even non-laser lights may provide some of the same benefits.

16 Mar 2011

Wound Management reviews alternatives to return to OTCBB

Wound Management Technologies, Inc., a leader in advanced wound care solutions, today commented on the shift in the Company's stock quotation coverage which recently transitioned from the OTCBB to the OTCQB under the symbol "WNDM."

16 Mar 2011

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

Covidien, a leading global provider of healthcare products, announced that new data on its hernia and abdominal wall repair products will be presented at Hernia Repair 2011, the 14th Annual Meeting & Scientific Program of the American Hernia Society.

15 Mar 2011

EHSI to sign definitive agreement with OceanBASIS

Emerging Healthcare Solutions, Inc. announced today that it is moving forward with negotiations toward a profit participation agreement with OceanBASIS, a German company specializing in stem-cell and marine-collagen technologies and products.

11 Mar 2011

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Santarus, Inc., a specialty biopharmaceutical company, today announced that it has initiated a Phase I clinical study with SAN-300, its anti-VLA-1 antibody.

10 Mar 2011

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, today announced it has reached the target enrollment for the double-blind placebo-controlled phase III program of XIAFLEX for the treatment of Peyronie's disease.

9 Mar 2011

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

Cardium Therapeutics today announced the publication of positive findings from the Company's Matrix Phase 2b clinical study.

9 Mar 2011

New nitric oxide producing topical products support healing process

GeNOsys, Inc. announced that it has developed a group of nitric oxide producing products for topical use. The products support blood flow and collagen growth to injured tissue and support the healing process.

9 Mar 2011

New, inexpensive method to accurately differentiate between benign and malignant breast tumors

Recent research by doctoral student Sevan Goenezen holds the promise of becoming a powerful new weapon in the fight against breast cancer. His complex computational research has led to a fast, inexpensive new method for using ultrasound and advanced algorithms to differentiate between benign and malignant tumors with a high degree of accuracy.

4 Mar 2011

Scientists receive $2 million NIH grant to improve orthopedic surgery using biomimetic patch

Two Washington University in St. Louis scientists are imitating nature as they attempt to solve one of the most difficult problems in orthopedic surgery: reattaching tendon to bone.

1 Mar 2011

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Medtronic, Inc. today announced that it has completed the purchase of rights to a chitosan-dextran gel technology from Adelaide Research & Innovation Pty Ltd. in Australia, Robinson Squidgel Ltd., and Otago Innovation Ltd. in New Zealand. Medtronic is acquiring this technology for potential use in developing future products for functional endoscopic sinus surgery (FESS).

25 Feb 2011

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Exelixis, Inc. today reported updated interim data from the cohort of patients with metastatic castration-resistant prostate cancer (CRPC) treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial.

18 Feb 2011

Integra launches Trel-XPress Demineralized Bone Matrix for orthopedic reconstruction surgery

Integra LifeSciences Holdings Corporation announced today the launch of Trel-XPress Demineralized Bone Matrix, expanding its portfolio of bone grafting substitutes for the orthopedic extremity reconstruction surgeon, which includes Integra OS Osteoconductive Scaffold, a synthetic bone void filler manufactured from beta tri-calcium phosphate and type I bovine collagen; Trel-X, a demineralized bone matrix; and Trel-XC, a demineralized bone matrix premixed with cancellous bone.

16 Feb 2011

State court jury rules in favor of Merck in FOSAMAX trial

Merck & Co., Inc. today said a state court jury in New Jersey found in its favor in the Rosenberg v. Merck case, rejecting the claims of a woman who blamed her dental and jaw related problems on her FOSAMAX use.

15 Feb 2011

Study shows beneficial anti-fibrotic effects of Pentraxin-2 in idiopathic pulmonary fibrosis

Promedior, Inc., a clinical stage biotechnology company developing novel therapies to treat fibrotic and inflammatory diseases, announced today the publication of collaborative research in the International Journal of Biochemistry and Cell Biology entitled, "TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P."

14 Feb 2011

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

11 Feb 2011

Orthovita receives 510(k) clearance to market Vitoss BA Bimodal Bone Graft Substitute

Orthovita, Inc., an orthobiologics and biosurgery company, announced today that it received 510(k) clearance from the U.S. Food and Drug Administration to market Vitoss BA Bimodal Bone Graft Substitute as a non-structural bone void filler for use in the extremities, pelvis and posterolateral spine.

10 Feb 2011

Collagen News and Research

Latest Collagen News and Research

Rxi's new RNAi preclinical data to be presented at Keystone conference

FibroGen, Astellas advance FG-4592 to phase 2b development for treatment of anemia in chronic kidney disease

Electric devices can improve aging skin

Non-laser light treatments may help treat common skin conditions

Wound Management reviews alternatives to return to OTCBB

Covidien to present new data on hernia, abdominal wall repair products at San Francisco

EHSI to sign definitive agreement with OceanBASIS

Santarus commences SAN-300 Phase I clinical study to treat inflammatory diseases

Auxilium completes patient enrollment in XIAFLEX phase III trial against Peyronie's disease

Wound Repair and Regeneration publishes positive findings from CXM's Matrix Phase 2b clinical study

New nitric oxide producing topical products support healing process

New, inexpensive method to accurately differentiate between benign and malignant breast tumors

Scientists receive $2 million NIH grant to improve orthopedic surgery using biomimetic patch

Medtronic acquires chitosan-dextran gel technology for use in functional endoscopic sinus surgery

Positive interim data from cabozantinib Phase 2 metastatic castration-resistant prostate cancer trial

Integra launches Trel-XPress Demineralized Bone Matrix for orthopedic reconstruction surgery

State court jury rules in favor of Merck in FOSAMAX trial

Study shows beneficial anti-fibrotic effects of Pentraxin-2 in idiopathic pulmonary fibrosis

Study reveals beneficial anti-fibrotic effects of Pentraxin-2 in TGFβ1-induced lung disease

Orthovita receives 510(k) clearance to market Vitoss BA Bimodal Bone Graft Substitute

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Collagen News and Research

Latest Collagen News and Research

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in